We aimed to compare the classic Light's criteria with different testing strategies in an effort to improve the accuracy of pleural¯uid (PF) categorization. Thirty-two patients with transudates and 140 with exudates on the basis of their clinical diagnosis were entered into the study. We examined the discriminative properties of 10 analytes in the identi®cation of PF, both singly and in combination with an`or' rule, to see which was best in distinguishing a transudate from an exudate. A combination of PF lactate dehydrogenase (LD) 7 307 U/L (two-thirds of the upper limit of the serum LD reference range) with either PF cholesterol 7 1´55 mmol/L or PF to serum protein ratio 7 0.5 had a diagnostic accuracy similar to that of Light's criteria. We suggest the use of PF LD and cholesterol in combination as an alternative method for distinguishing pleural transudates from exudates. This test combination avoids the need for venepuncture and the simultaneous collection of a blood sample.
The ®rst step in the evaluation of pleural effusions is to classify them as transudates or exudates. Transudates are ultra®ltrates of plasma in the pleura that arise from a limited, de®ned group of causes. In contrast, exudates are produced by a variety of in¯ammatory or malignant conditions. The main reason to differentiate transudates from exudates is that if the pleural¯uid (PF) is a transudate no further diagnostic procedures are necessary, whereas an exudate is indicative of the need for a more extensive diagnostic investigation. 1 For the last two decades, the criteria most commonly used to distinguish transudates from exudates have been dependent on the measurement of lactic dehydrogenase (LD) and protein in both PF and serum (Light's criteria). 2 Exudative effusions meet at least one of the following criteria, whereas transudates meet none: PF protein divided by serum protein (PF/S protein) greater than 0´5, PF LD divided by serum LD (PF/S LD) greater than 0´6, and PF LD greater than two-thirds the upper limit the serum LD reference range. Light's criteria have demonstrated excellent discriminative properties, but other available tests, either singly (e.g. PF cholesterol, 3, 4 PF/S cholesterol ratio, 5 PF/S cholinesterase ratio, 6 serum-PF albumin gradient, 7,8 PF/S bilirubin ratio 9 ) or in combination (e.g. PF cholesterol and LD, 10±13 PF protein and LD and cholesterol 11 ) are also able to discriminate. Controversy therefore exists as to which method is more accurate. The aim of the present study was to compare the relative utility of various PF parameters, including cholesterol, cholinesterase and alkaline phosphatase, in distinguishing a transudate from an exudate.
PATIENTS AND METHODS
We prospectively evaluated 223 consecutive patients admitted to our hospital with pleural effusion, who underwent a diagnostic thoracocentesis between November 1996 and January 1999. The following studies were performed on all PF: differential cell count, protein, glucose, LD, adenosine deaminase, cholesterol, cholinesterase, pH, bacterial and mycobacterial cultures and cytology. A simultaneous serum sample was also obtained to measure LD activity and protein concentration. PF and serum alkaline phosphatase were also measured in approximately one-third of patients. Further investigations, such as pleural biopsy, were done at the discretion of the primary physicians. The clinical
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Ann Clin Biochem 2001; 38: 671±675 diagnoses of the patients were de®ned by known predetermined criteria. 12, 14 Speci®cally, criteria for transudates required the exclusion of any disease associated with exudative effusions, and 3 or more months of prior patient observation. All biochemical measurements were performed on a selective discrete multichannel analyser (Hitachi 917) using standard methodology. Cell counts were performed manually in a Thoma's chamber.
The criteria for identi®cation of an exudative pleural effusion were: pleural red cell count 7 102 10 9 /L; 15 pleural white cell counts 7 1´02 10 9 /L; 15 PF protein 7 30 g/L; 16 PF LD 7 307 U/L (more than two-thirds the upper limits of the reported serum reference range of 240±460 U/L); 1 PF/S protein 7 0´5; 1 PF/S LD 7 0´6; 1 PF alkaline phosphatase 7 45 U/L; 17 PF/ S alkaline phosphatase7 0´15; 17 PF cholesterol at variable cut-off values (7 1´16, 10 7 1´3 12 and 7 1´55 mmol/L); 3, 13 and PF cholinesterase 7 1600 U/L, a cut-off corresponding to a diagnostic speci®city of 90%. Non-parametric receiver operating (ROC) analysis allowed a general measure of diagnostic accuracy of the tests. The test with the higher area under the curve (AUC) has the greater discriminative properties. Sensitivity, speci®city, positive predictive value, negative predictive value and odds ratios with 95% con®dence intervals (CI) were calculated for the selected cut-off points. We made comparisons between Light's criteria (9), pericardial disease (7), systemic lupus erythematosus (2), sarcoidosis (1), Wegener's granulomatosis (1). and the test combinations in a parallel manner with an`or' rule, wherein positivity of any one of the combined tests represents a positive result. Test combinations were derived from a multivariate logistic regression model which included only parameters with more than 75% speci®city.
RESULTS
Of the 223 patients studied, 51 (23%) were excluded because of uncon®rmed aetiology, multifactorial disease or improper handling of PF prior to analysis. Of the remaining 172 pleural effusions, 32 (18´6%) were transudates (19 men and 13 women, mean age 75 8 years) and 140 (81´4%) were exudates (86 men and 54 women, mean age 56 19 years). The diagnoses are listed in Table 1 . Table 2 shows the accuracy of each criterion used. PF cholesterol 7 1´55 mmol/L, PF/S protein 7 0´5 and PF/S LD 7 0´6 showed the highest odds ratios. The higher the odds ratio, the greater the diagnostic value of the test, and values greater than 50 identify tests with good discriminative properties. An odds ratio of greater than 50 was obtained if the PF cholesterol was 7 1´3 mmol/ L and PF LD was 7 307 U/L, and was nearly reached by a PF cholinesterase 7 1600 U/L and PF protein 7 30 g/L. As expected, PF cell count had the lowest diagnostic accuracy of the individual tests studied. PF alkaline phosphatase and its ratio to serum had an unacceptably low speci®city.
The incremental diagnostic value of combined tests that discriminate between exudates and transudates is shown in Table 3 . The logistic regression model selected PF LD 7 307 U/L and PF/S protein 7 0´5 when PF cholesterol 7 1´3 mmol/L entered the model. However, if the cut-off for PF cholesterol was set at 1´55 mmol/L, the parameters selected by the statistic model were PF LD 7 307 U/L and PF cholesterol. Overlap of odds ratio CI indicated that no single test combination could be clearly identi®ed as being superior to others. The percentages of effusions misclassi®ed by Light's criteria and the alternative criteria were similar (6´4%). Thus, using Light's criteria, 11 patients were incorrectly classi®ed: eight pleural effusions secondary to heart failure and three malignant effusions, two of which were reported in a retrospective series. 18 One had a lung cancer producing atelectasis, a known cause of transudate. The other died prematurely from a disseminated malignancy and the cause of transudate is unknown. The third had breast cancer and a malignant exudate con®rmed by cytology, and was also in congestive heart failure. The other criteria derived from the logistic regression model misclassi®ed six transudates of cardiac origin (as Light's criteria) and ®ve exudates (including the three malignant effusions falsely ascribed by Light's criteria and two more from the miscellaneous group).
DISCUSSION
This study is one in a series of attempts to compare Light's criteria with recently proposed biochemical parameters to distinguish pleural transudates from exudates. Although the criteria ®rst proposed by Light et al. 2 have become the gold standard for identifying exudative effusions, these tests require simultaneous measurement of PF and serum protein and LD. We conclude that measurement of cholesterol and LD in PF can substitute for Light's criteria in the identi®cation of exudates, with the advantage of not requiring serum test results to calculate a ratio. Furthermore, dropping PF/S LD from Light's criteria does not decrease its diagnostic accuracy, an option which is of bene®t to clinicians when serum LD is unavailable.
In recent years other researchers have reassessed Light's criteria looking for new cut-off points that could improve their discriminatory capacity. Romero et al. 19 found that using the following new cut-off points ± 0´6 for the PF/S protein, 280 U/L for PF LD, and 0´9 for PF/S LD ± the accuracy of Light's criteria remained practically unmodi®ed whereas the speci®city rose from 77% to 93%. Heffner et al. 11 performed a meta-analysis involving 1448 patients and found that performing three tests on a single PF sample could discriminate between transudates and exudates as accurately as using paired (PF LD 7 0´45 times the upper limit of normal serum, or PF cholesterol 7 1´16 mmol/L) and triplet combinations (PF protein 7 29 g/L or PF LD 7 0´45 times the upper limit of normal serum, or PF cholesterol 7 1´16 mmol/L). However, we have previously observed that changing the cut-off points of Light's criteria up 14 or down 20 offers no advantages for discriminating between transudative and exudative pleural effusions. PF cholesterol measurements, using different cut-off valves, have also been proposed to aid PF differentiation. In the present study, using higher cut-off levels of PF cholesterol (7 1´55 mmol/L instead of 7 1´16 or 7 1´3 mmol/L), speci®city was improved without markedly decreasing sensitivity, although the differences did not reach statistical signi®cance. In addition, both PF cholinesterase and PF alkaline phosphatase appeared to be less satisfactory than previously reported. 6, 21 The former had less sensitivity than Light's criteria, whereas the latter showed an unacceptable speci®city.
In this study the use of Light's criteria maximized sensitivity (97´9%) at the expense of speci®city (74´2%). This may lead to misdiagnosis and unwarranted invasive interventions in some patients with transudates. Furthermore, speci®city was not greatly improved by using the alternative paired combinations outlined in Table 3 . In contrast, only 2´1% and 3´6% of exudates were incorrectly classi®ed by the classic and alternative criteria, respectively.
Several reports have supported our observation that measurements on PF only may be costeffective and convenient, and also as accurate as using Light's criteria. 10±13 
